Assuntos
Antineoplásicos/efeitos adversos , Síndrome de Hipersensibilidade a Medicamentos/etiologia , Indóis/efeitos adversos , Sulfonamidas/efeitos adversos , Idoso de 80 Anos ou mais , Antineoplásicos/uso terapêutico , Síndrome de Hipersensibilidade a Medicamentos/fisiopatologia , Feminino , Humanos , Indóis/uso terapêutico , Melanoma/tratamento farmacológico , Inibidores de Proteínas Quinases/efeitos adversos , Inibidores de Proteínas Quinases/uso terapêutico , Proteínas Proto-Oncogênicas B-raf/antagonistas & inibidores , Neoplasias Cutâneas/tratamento farmacológico , Sulfonamidas/uso terapêutico , VemurafenibRESUMO
Burn wound progression refers to the phenomenon of continued tissue necrosis in the zone of stasis after abatement of the initial thermal insult. A multitude of chemical and mechanical factors contribute to the local pathophysiologic process of burn wound progression. Prolonged inflammation results in an accumulation of cytotoxic cytokines and free radicals, along with neutrophil plugging of dermal venules. Increased vascular permeability and augmentations of interstitial hydrostatic pressure lead to edema with vascular congestion. Hypercoagulability with thrombosis further impairs blood flow, while oxidative stress damages endothelial cells and compromises vascular patency. A number of studies have investigated the utility of various agents in modulating these mechanisms of burn wound progression. However, as many of studies have used animal models of burn injury, often with administration of therapy preburn, obscuring the clinical applicability of the results to burn patients is of questionable benefit. An understanding of the complex, interrelated mediators of burn wound progression and their ultimate point of convergence in effecting tissue necrosiscell apoptosis or oncosiswill allow for the future development of therapeutic interventions.
Assuntos
Queimaduras/fisiopatologia , Apoptose/fisiologia , Transtornos da Coagulação Sanguínea/fisiopatologia , Citocinas/metabolismo , Progressão da Doença , Edema/fisiopatologia , Radicais Livres/metabolismo , Humanos , Inflamação/fisiopatologia , Necrose , Fatores de RiscoRESUMO
Determining the underlying etiology of recurrent erythema multiforme (EM) can be a difficult endeavor. Although infection with herpes simplex virus (HSV) has been implicated in some cases, the precise trigger of a given patient's recurrent EM often remains elusive. We discuss the case of a woman with a recurrent blistering eruption that was clinically and histopathologically consistent with EM. An investigation into the etiology of the patient's EM suggested that HSV was not the causative factor but instead pointed toward a hormonal influence that we interpret as autoimmune progesterone dermatitis (APD). This case is presented to highlight the importance of considering hormonal triggers in women with recurrent EM that consistently flares during the luteal phase of the menstrual cycle, the point at which serum progesterone levels peak. A brief review of the literature regarding the diagnosis, histopathology, etiology and treatment of APD is further provided.